Skip to main content
Premium Trial:

Request an Annual Quote

People In The News: Dec 28, 2012

NEW YORK (GenomeWeb News) – Molecular diagnostics developer Health Discovery Corporation has named John Norris to be its new CEO, taking over the helm from Stephen Barnhill, who founded the company and has been its chairman and CEO for nine years.

Norris has been promoted from the posts of executive VP, chief technology officer, and chief regulatory officer.

He formerly was COO of the US Food and Drug Administration, he was CEO and is still chairman of the FDDH (Food, Drug, Device, and Healthcare), a coaching firm, and he still is chairman of Needlebot, a next-generation healthcare software search engine.

Norris also has been a consultant to management at Pfizer, Merck, Johnson and Johnson, and Glaxo.


US President Barack Obama has named Institute for Systems Biology President Leroy Hood and Frederick Hawthorne, director of the Institute of Nano and Molecular Medicine at the University of Missouri at Columbia, as two of the 12 new winners of its National Medal of Science awards.


The American Board of Genetic Counseling has tapped Susan Estabrooks Hahn of the Miller School of Medicine at the University of Miami as its president-elect.

Hahn is an instructor at the John T. Macdonald Foundation Department of Human Genetics at the Miller School. Hahn will serve as president-elect for ABCG in 2013 and as president in 2014.

The ABCG is a credentialing organization that provides certification for the genetic counseling profession in the US and Canada.

Hahn also is assistant director of communications, compliance, and ethics at the Hussman Institute for Human Genomics.


Rosetta Genomics' shareholders have elected Yitzhak Peterburg to serve on its board of directors. Peterburg has been a consultant for the company over the most recent quarter, and he currently serves on the board of directors at TEVA Pharmaceuticals, where he previously was senior VP and head of global branded products.

Peterburg also spent a dozen years at Israel's Clalit Health Services, where he held a number of positions, including general manager, head of the Health Policy Division, and CIO of the Medical Division, and was the CEO post at Soroka University Medical Center,


Simon Tavaré has been named director of the Cancer Research UK Cambridge Institute. Tavaré has been a professor in the Oncology Department and a professor of applied mathematics and theoretical physics at the University of Cambridge since 2003.

His work has focused on statistical methods for studying cancer that rely on population genetics, cancer genomics, and DNA sequencing.


Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People In The News, a weekly roundup of industry comings and goings.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.